55 related articles for article (PubMed ID: 37354441)
1. Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission.
Sugiyama M; Arakawa A; Kogure Y; Shirakawa N; Watanabe M; Ito Y; Tanimura K; Tao K; Nakajima M; Watanabe Y; Miyagi-Maeshima A; Fukuhara S; Kataoka K; Izutsu K; Fukuda T; Ogawa C
Pediatr Blood Cancer; 2024 Jan; 71(1):e30721. PubMed ID: 37833848
[No Abstract] [Full Text] [Related]
2. Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
Loscocco GG; Ascani S; Mannelli F; Zanelli M; Rotunno G; Santi R; Vannucchi AM
Am J Hematol; 2023 Dec; 98(12):1959-1962. PubMed ID: 37435901
[No Abstract] [Full Text] [Related]
3. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
4. Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review.
McKeague SJ; O'Rourke K; Fanning S; Joy C; Throp D; Adams R; Harvey Y; Keng TB
Am J Clin Pathol; 2024 Feb; 161(2):197-205. PubMed ID: 37855739
[TBL] [Abstract][Full Text] [Related]
5. Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of
Zhang L; Zhu X; Qu W; Lu Y; Feng Z; Zhao L
Haematologica; 2023 Dec; 108(12):3506-3510. PubMed ID: 37102606
[No Abstract] [Full Text] [Related]
6. Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.
Wang J; Xu L; Li Y; Wang J; Shao Y; Lai W; Yong J; Zhao L; Wei X; Gao C; Liu D; Gao X; Zhang Y
Leuk Lymphoma; 2024 Apr; 65(4):521-525. PubMed ID: 38157478
[No Abstract] [Full Text] [Related]
7. A novel
Jiménez-Vicente C; Garrote M; López-Guerra M; Villamón E; Guijarro F; Perez-Valencia AI; Martinez-Roca A; Balaguer O; Álvarez-Larrán A; Hernández-Boluda JC; Rovira M; Colomer D; Diaz-Beyá M; Rozman M; Esteve J
Leuk Lymphoma; 2024 Mar; 65(3):394-398. PubMed ID: 38117930
[No Abstract] [Full Text] [Related]
8. Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2.
Romagnoli S; Bartalucci N; Gesullo F; Balliu M; Bonifacio S; Fernandez AGL; Mannelli F; Bolognini D; Pelo E; Mecucci C; Guglielmelli P; Vannucchi AM
Biomark Res; 2021 Nov; 9(1):83. PubMed ID: 34772467
[TBL] [Abstract][Full Text] [Related]
9. Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography.
Kobayashi H; Okamoto S; Fujishima M
EJHaem; 2023 Nov; 4(4):1182-1183. PubMed ID: 38024625
[No Abstract] [Full Text] [Related]
10. Hematological Neoplasms with Eosinophilia.
Morales-Camacho RM; Caballero-Velázquez T; Borrero JJ; Bernal R; Prats-Martín C
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254826
[TBL] [Abstract][Full Text] [Related]
11. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
[No Abstract] [Full Text] [Related]
12. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
13. The power of the partner: defying expectations in a case of a myeloproliferative neoplasm with FGFR1 rearrangement.
Wilberger AC; McMahon B; Ewalt MD
Leuk Lymphoma; 2019 Apr; 60(4):1095-1097. PubMed ID: 30277124
[No Abstract] [Full Text] [Related]
14. Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and
Yan Y; Qu S; Liu J; Li C; Yan X; Xu Z; Qin T; Jia Y; Pan L; Gao Q; Jiao M; Li B; Gale RP; Xiao Z
Leuk Lymphoma; 2023 Sep; 64(9):1605-1610. PubMed ID: 37354441
[No Abstract] [Full Text] [Related]
15. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.
Verstovsek S; Subbiah V; Masarova L; Yin CC; Tang G; Manshouri T; Asatiani E; Daver NG
Ann Oncol; 2018 Aug; 29(8):1880-1882. PubMed ID: 29767670
[No Abstract] [Full Text] [Related]
16. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
